ProShare Advisors’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.16M | Sell |
|
|||||
|
2025
Q2 | $1.01M | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $252K | Sell |
|
|||||
|
2024
Q2 | $301K | Sell |
|
|||||
|
2024
Q1 | $395K | Buy |
|
|||||
|
2023
Q4 | $329K | Sell |
|
|||||
|
2023
Q3 | $242K | Buy |
|
|||||
|
2023
Q2 | $295K | Sell |
|
|||||
|
2023
Q1 | $263K | Sell |
|
|||||
|
2022
Q4 | $312K | Sell |
|
|||||
|
2022
Q3 | $510K | Buy |
|
|||||
|
2022
Q2 | $437K | Sell |
|
|||||
|
2022
Q1 | $602K | Sell |
|
|||||
|
2021
Q4 | $817K | Sell |
|
|||||
|
2021
Q3 | $1.82M | Buy |
|
|||||
|
2021
Q2 | $2.2M | Buy |
|
|||||
|
2021
Q1 | $1.27M | Sell |
|
|||||
|
2020
Q4 | $1.67M | Sell |
|
|||||
|
2020
Q3 | $946K | Buy |
|
|||||
|
2020
Q2 | $717K | Buy |
|
|||||
|
2020
Q1 | $348K | Sell |
|
|||||
|
2019
Q4 | $783K | Sell |
|
|||||
|
2019
Q3 | $607K | Sell |
|
|||||
|
2019
Q2 | $727K | Sell |
|
|||||
|
2019
Q1 | $634K | Buy |
|
|||||
|
2018
Q4 | $505K | Sell |
|
|||||
|
2018
Q3 | $861K | Sell |
|
|||||
|
2018
Q2 | $1.17M | Sell |
|
|||||
|
2018
Q1 | $973K | Sell |
|
|||||
|
2017
Q4 | $519K | Buy |
|